Improving health and social care through evidence-based guidance

Find NICE guidance

Browse guidance by area:

Conditions and diseases

Health and social care delivery

Health protection

Lifestyle and wellbeing

Population groups

Settings

  • About us
  • Put guidance into practice
  • Find journals and databases
  • Financial planning
  • Get involved

Latest guidance  

Butterfly iQ+ for diagnostic ultrasound imaging
Free-functioning gracilis transfer to restore upper limb function in brachial plexus injury
Cytoreduction surgery with hyperthermic intraoperative peritoneal chemotherapy for peritoneal carcinomatosis
Lenalidomide maintenance treatment after an autologous stem cell transplant for newly diagnosed multiple myeloma
Baricitinib for treating moderate to severe atopic dermatitis

Latest guidance in consultation  

Solriamfetol for treating excessive daytime sleepiness caused by narcolepsy [ID1602]
Olaparib for previously treated, hormone-relapsed metastatic prostate cancer with homologous recombination repair gene mutations [ID1640]
Babies, children and young people's experience of healthcare
Guselkumab for treating active psoriatic arthritis after inadequate response to DMARDs [ID1658]
Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s

Explore NICE

  1. News|
  2. About|
  3. Events|
  4. Get involved

Survey: what would you like to know more about?

NICE impact report: cardiovascular disease management

NICE and LSE's MSc Evaluation of Health Care Interventions and Outcomes

Support for industry to engage with us during health technology development

Reviewing our process for health technology evaluation: consultation

Join us for the virtual launch of our new 5-year strategy on Monday 19 April - register now

Latest news  

  1. Register now for the HTAi 2021 Virtual Annual Meeting
  2. Thousands of breast cancer patients to have routine access to NICE-approved drug combination
  3. Hundreds of people set to benefit as NICE recommends selective internal radiation therapy for treating advanced liver cancer
  4. NICE draft guidance recommends sapropterin for children with rare inherited metabolic condition phenylketonuria

Tweets

by @NICEcomms
Tweets by NICEcomms
Tweets by NICEcomms